05.09.2016 Views

CONGRESS GUIDE

ExportFinalProgram_26082016041327

ExportFinalProgram_26082016041327

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ERS International Congress 2016<br />

DETAILED PROGRAMME<br />

WEDNESDAY 07 SEPTEMBER, 2016<br />

OA4823<br />

OA4824<br />

OA4825<br />

OA4826<br />

OA4827<br />

Active tuberculosis increases the risk of incident osteoporosis- A nation-wide population based cohort study<br />

Jia-Yih Feng (Taipei, Taiwan), Jia-Yih Feng, Ying-Ying Chen, Yung-Feng Yen, Sheng-Wei Pan, Wei-Juin Su<br />

Facilities for treating multidrug-resistant tuberculosis (MDRTB) in Europe<br />

Graham H. Bothamley (London, United Kingdom), Graham H. Bothamley, Christoph Lange<br />

A prediction rule to stratify mortality risk of patients with pulmonary tuberculosis<br />

Helder Novais e Bastos (Braga, Portugal), Helder Novais e Bastos, Nuno Osório, António Gil Castro, Angélica Ramos,<br />

Teresa Carvalho, Leonor Meira, David Araújo, Leonor Almeida, Rita Boaventura, Patrícia Fragata, Catarina Chaves,<br />

Patrício Costa, Ivo Ferreira, Sara Magalhães, Fernando Rodrigues, Rui Sarmento Castro, Raquel Duarte, João Tiago<br />

Guimarães, Margarida Saraiva<br />

Breast tuberculosis in East London<br />

Benjamn Butler (London, United Kingdom), Benjamn Butler, Amina Khanam, Jessica Potter, Charlotte Longman, Thomas<br />

Campion, Silvia O’Keeffe, Simon Tiberi, Matthew Burman, Nivenka Jayasekera, Veronica White, Heinke Kunst<br />

Genotypes of mycobacterium tuberculosis with pre-extended drug resistance in Belarus<br />

Veronika Slizen (Minsk, Belarus), Veronika Slizen, Larissa Surkova<br />

OA4828<br />

Dynamics of primary multidrug drug resistance in Novokuznetsk over 10 years period<br />

Arkadiy Khanin (Novokuznetsk, Kemerovo Oblast, Russian Federation), Arkadiy Khanin, Irina Viktorova, Sergey Dolgikh,<br />

Irina Garavskaya<br />

Room K Session 695 08:30 - 10:30<br />

Oral Presentation: Novel strategies on COPD and asthma management<br />

Chairs : Klaus Friedrich Rabe (Großhansdorf, Germany), Omar Usmani (London, United Kingdom)<br />

OA4829<br />

LATE-BREAKING ABSTRACT: Real life impact of long acting beta-2-agonist withdrawal in controlled step 3<br />

asthma patients<br />

Sunny Jabbal (Dundee, United Kingdom), Sunny Jabbal, Arvind Manoharan, William Anderson, Joseph Lipworth, Brian<br />

Lipworth<br />

OA4830<br />

OA4831<br />

OA1791<br />

OA4833<br />

OA4834<br />

OA4835<br />

LATE-BREAKING ABSTRACT: The benefits of [italic]Nigella sativa[/italic] oil supplementation on asthma<br />

inflammation: A randomised, double-blind, placebo-controlled, phase II trial<br />

Abdulrahman Koshak (London, United Kingdom), Abdulrahman Koshak, Li Wei, Emad Koshak, Siraj Wali, Omer<br />

Alamoudi, Abdulrahman Demerdash, Majdy Qutub, Peter Pushparaj, Michael Heinrich<br />

LATE-BREAKING ABSTRACT: Association of incident pneumonia and exacerbations with extrafine<br />

beclometasone dipropionate/formoterol (BDP/FF) in severe COPD patients: A post-hoc analysis of FORWARD study<br />

Massimo Corradi (Parma, Italy), Massimo Corradi, Monica Spinola, Alessandro Guasconi, Géraldine Cohuet, Isabella<br />

Montagna, Andrea Bizzi, Stefano Petruzzelli<br />

LATE-BREAKING ABSTRACT: Benralizumab for mild to moderate, persistent asthma: The BISE phase III study<br />

Gary T. Ferguson (Farmington Hills, United States of America), Gary Ferguson, J. Mark FitzGerald, Eugene Bleecker,<br />

Michel Laviolette, David Bernstein, Craig LaForce, Lyndon Mansfield, Peter Barker, Yanping Wu, Maria Jison, Mitchell<br />

Goldman<br />

LATE-BREAKING ABSTRACT: Indacaterol/glycopyrronium (IND/GLY) reduces the risk of exacerbations versus<br />

salmeterol/fluticasone (SFC) in moderate-to-very severe COPD patients irrespective of prior ICS/LABA/LAMA<br />

therapy: The FLAME study<br />

Wisia Wedzicha (London, United Kingdom), Jadwiga Wedzicha, Karen Mezzi, Tim Ayers, Chau Thach, Robert Fogel,<br />

Francesco Patalano, Donald Banerji<br />

LATE-BREAKING ABSTRACT: Pulmonary deposition of a novel LAMA/LABA Co-Suspension[sup][trade][/sup]<br />

technology glycopyrronium/formoterol (GFF) MDI in healthy subjects (PT003020)<br />

Sarvajna Dwivedi (Redwood City, United States of America), Glyn Taylor, Simon Warren, Chad Orevillo, Andrea Maes,<br />

Ubaldo J. Martin, Sarvajna Dwivedi, Colin Reisner<br />

LATE-BREAKING ABSTRACT: IgE immunadsorption in allergic bronchopulmonary aspergillosis: A pilot study<br />

Siva Mahendran (Watford, United Kingdom), Siva Mahendran, Rosemary Ebling, Mohammad Ibrahim, Tariq Sethi<br />

OA4836<br />

LATE-BREAKING ABSTRACT: Corticosteroid responsiveness in COPD<br />

Nausherwan Burki (Farmington, United States of America), Nausherwan Burki, Marsden Granger, Debapriya Datta<br />

Room ICC Capital Suite<br />

11<br />

Session 696 08:30 - 10:30<br />

Poster Discussion: Lung cancer: therapeutic modalities, re-staging, and follow-up<br />

313 26.08.2016

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!